2 fantastic ASX growth shares to buy this month

ResMed Inc. (ASX:RMD) and this ASX growth share could be ones to buy in January. Here's why they are rated highly…

| More on:
A young boy sits on his dad's shoulders while both flex their muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add a growth share or two to your portfolio this month? Then take a look at the two ASX shares listed below.

Here's why they could be growth shares to buy right now:

Kogan.com Ltd (ASX: KGN)

The first growth share to look at is this ecommerce company. It has been a very strong performer over the last 12 months thanks to the accelerating shift to online shopping. With shops shutting at the height of the pandemic and people being locked down, millions of consumers went online for their shopping. This gave Kogan's performance a major boost, leading to explosive growth in FY 2020.

Pleasingly, although life is getting back to normal, consumers are still flocking online for shopping. This has led to Kogan's strong growth continuing in FY 2021. For example, during the first four months of FY 2021, Kogan's sales were up 99.8% and its operating earnings were up 268.8% over the same period last year.

In addition to this, the company has acquired online retailer Mighty Ape for NZ$120 million and furniture retailer Matt Blatt for $4.4 million. These additions look set to give its second half performance a boost.

Canaccord Genuity is a fan of Kogan and has a buy rating and $25.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another growth share to look at is ResMed. Its is a medical device company with a focus on the fast-growing sleep treatment market.

ResMed also manufactures ventilators, which have been in high demand during the pandemic. In fact, demand has been so strong, it offset softness in the sleep treatment side of the business and underpinned a very strong result in FY 2020 and stellar growth in the first quarter of the new financial year.

While COVID is likely to stifle the growth of the sleep treatment business in the near term, as fewer people are diagnosed with sleep apnoea, it has been tipped to accelerate its growth once trading conditions improve.

Analysts at Morgans are positive on the company. This week the broker retained its add rating and $30.99 price target on ResMed's shares. While it acknowledges that it could be facing some headwinds, it believes its future remains bright thanks to its new product pipeline and growing digital business.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

Forget PLS shares! This ASX growth stock is tipped to rise 60% by 2027

Could this beaten down stock follow PLS' lead and rebound strongly. Bell Potter thinks it could.

Read more »

2 smiling women looking at a phone.
Growth Shares

My 3 higher-risk, high-reward ASX stock recommendations for February 2026

For investors willing to accept uncertainty, selective risk can sometimes be rewarded.

Read more »

A couple and their baby sit together at their computer carrying out digital transactions and smiling happily.
Growth Shares

The bulls are coming: 2 of the best ASX growth shares to buy now to get ahead

When the bulls return, I think these shares could be in demand with investors.

Read more »

Man flies flat above city skyline with rocket strapped to back
Growth Shares

2 ASX growth stocks set to skyrocket in the next 12 months

Analysts are predicting returns of 80% to 130% from these stocks.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Growth Shares

3 underappreciated ASX growth shares I would buy with $1,000

Not all growth opportunities are obvious at first glance. These three ASX shares have earnings potential that may be underappreciated.

Read more »

US navy ship at sea.
Growth Shares

Another record in sight? Why this ASX defence stock is back in rally mode

EOS shares surge toward fresh highs as defence spending accelerates and a key South Korean contract decision looms.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

5 of the best ASX growth shares to buy and hold

Analysts are bullish on these growth shares. Let's find out why.

Read more »

A woman sends a paper plane soaring into the sky at dusk.
Growth Shares

2 ASX 200 shares to buy and hold for 10 years

Both stocks offer credible paths to wealth creation.

Read more »